Progress in clinical application of 125I seeds brachytherapy in the treatment of oral and maxillofacial malignant tumors
10.3760/cma.j.cn321828-20230726-00013
- VernacularTitle:125I粒子近距离照射在口腔颌面部恶性肿瘤治疗中的临床应用进展
- Author:
Ting WEI
1
;
Qianwei NI
;
Zigeng YANG
;
Xiaoyong HUANG
;
Haitao SUN
;
Ruizhe SUN
;
Chao MA
;
Bingbing CAI
;
Zhan GAO
Author Information
1. 新疆医科大学研究生院，乌鲁木齐 830054
- Keywords:
Mouth neoplasms;
Brachytherapy;
Iodine radioisotopes;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2024;44(4):253-256
- CountryChina
- Language:Chinese
-
Abstract:
Oral and maxillofacial malignant tumors threaten the life and health of patients, and seriously affect their swallowing, language function and face. 125I seeds brachytherapy for oral and maxillofacial malignant tumors has been widely concerned and studied because of its advantages such as less surgical trauma, large and uniform dose distribution in the target tissue, little damage to the surrounding normal tissue, and reducing radiation exposure of medical staff. Low-dose brachytherapy with 125I seeds can effectively reduce the tumor volume and prolong the survival time of patients. This article reviews the clinical application of 125I seeds brachytherapy in oral and maxillofacial malignant tumors.
